Solublized fractalkine is a key regulator of the microglial proinflammatory response, where it is has been shown to protect against microglia-mediated DA neurotoxicity in vitro and in PD models in vivo (Re and Przedborski 2006). Here, CX3CL1 is linked to Parkinson disease.